HCV E2 anticorps (N-Term)
Aperçu rapide pour HCV E2 anticorps (N-Term) (ABIN7469383)
Antigène
Voir toutes HCV E2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Hepatitis C Virus (HCV)
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the N-terminus region of Hepatitis C virus E2 protein (HCV 2a (strain JFH-1)). The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1XPBS ( pH 7), 40 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- HCV E2 (Hepatitis C Virus Envelope Protein E2 (HCV E2))
-
Autre désignation
- Hepatitis C Virus Envelope Protein E2
-
Sujet
- Hepatitis C Virus Envelope E2 , Hepatitis C Virus E2 , HCV Envelope E2 , HCV E2
Antigène
-